Is SYNDROS an option for you?Adult patients with Cancer and/or AIDS may benefit from SYNDROS (dronabinol) which is the First and Only FDA-Approved CII Tetrahydrocannabinol (THC), a liquid cannabinoid used to treat:
- Nausea and vomiting caused by anti-cancer medicine (chemotherapy) in people whose nausea and vomiting have not improved with usual anti-nausea medicines.
- Loss of appetite (anorexia) in people with AIDS (Acquired Immune Deficiency Syndrome) who have lost weight.
SYNDROS® is distributed by Benuvia Operations, LLC.
Chemotherapy-Induced Nausea and Vomiting (CINV)
Many adult patients on antiemetics still experience nausea and vomiting while receiving chemotherapy, 30-50% of adult patients receiving moderately or highly emetogenic chemotherapy continue to experience breakthrough CINV, despite the progressive introduction of antiemetic (anti-nausea) agents.
Anorexia Associated with Weight Loss in Adult Patients with AIDS
Many adult patients in the United States with AIDS may experience anorexia associated weight loss, despite the use of highly active antiretroviral therapy, it is estimated that the prevalence of HIV wasting syndrome is between 14% and 38%.